Beth E. Robie, MD
Obstetrics & Gynecology · Campbell
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Robie’s office at (408) 236-6400 to ask if they take your plan before you enroll.
California Medical Board record
Licence G59309 · Delinquent
Licence status: Delinquent · since 1986 · expires 2024-10-31 · University of Connecticut School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Drugs they prescribed that Part D paid
$470
Pharmacies billed $470 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 11) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
$470 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 11 | 11 | 0% (0) | None | $470 |
| 2023 | 162 | 102 | 0% (0) | 20% | $12,618 |
| 2022 | 411 | 179 | 0% (0) | 15% | $28,833 |
| 2021 | 350 | 130 | 0% (0) | 16% | $26,156 |
| 2020 | 275 | 96 | 0% (0) | 12% | $20,450 |
| 2019 | 252 | 97 | 0% (0) | 17% | $22,745 |
| 2018 | 229 | 94 | 0% (0) | 24% | $25,292 |
| 2017 | 206 | 87 | 0% (0) | 36% | $31,516 |
| 2016 | 238 | 92 | None | 36% | $37,059 |
| 2015 | 223 | 94 | 0% (0) | 39% | $27,829 |
| 2014 | 194 | 84 | 0% (0) | 36% | $21,589 |
| 2013 | 206 | 85 | 0% (0) | 35% | $18,518 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol | 61 | $2,281 | $37 |
| Adacel Tdap | 14 | $724 | $52 |
| Alendronate | 22 | $229 | $10 |
2022: 10 drugs
| Estring | 19 | $10,772 | $567 |
| Yuvafem | 26 | $4,400 | $169 |
| Estradiol | 127 | $3,916 | $31 |
| Climara | 15 | $2,251 | $150 |
| Progesterone | 22 | $1,229 | $56 |
| Adacel Tdap | 23 | $1,173 | $51 |
| Alendronate | 52 | $541 | $10 |
| Acyclovir | 22 | $372 | $17 |
| Clobetasol Propionate | 16 | $312 | $20 |
| Medroxyprogesterone Acetate | 17 | $287 | $17 |
2021: 10 drugs
| Estring | 19 | $10,436 | $549 |
| Estradiol | 111 | $4,573 | $41 |
| Yuvafem | 11 | $1,788 | $163 |
| Progesterone | 13 | $1,211 | $93 |
| Clindamycin Phosphate | 12 | $650 | $54 |
| Adacel Tdap | 12 | $600 | $50 |
| Clobetasol Propionate | 20 | $531 | $27 |
| Alendronate | 48 | $488 | $10 |
| Acyclovir | 14 | $374 | $27 |
| Medroxyprogesterone Acetate | 16 | $229 | $14 |
2020: 6 drugs
| Estring | 11 | $5,864 | $533 |
| Estradiol | 102 | $5,343 | $52 |
| Clobetasol Propionate | 21 | $450 | $21 |
| Alendronate | 42 | $437 | $10 |
| Acyclovir | 16 | $357 | $22 |
| Medroxyprogesterone Acetate | 13 | $214 | $16 |
2019: 5 drugs
| Estrace | 20 | $5,291 | $265 |
| Estradiol | 81 | $2,916 | $36 |
| Clobetasol Propionate | 17 | $971 | $57 |
| Alendronate | 52 | $552 | $11 |
| Medroxyprogesterone Acetate | 12 | $219 | $18 |
2018: 7 drugs
| Estring | 14 | $6,794 | $485 |
| Estrace | 52 | $6,755 | $130 |
| Climara | 11 | $1,617 | $147 |
| Clobetasol Propionate | 13 | $1,005 | $77 |
| Estradiol | 32 | $705 | $22 |
| Alendronate | 37 | $459 | $12 |
| Medroxyprogesterone Acetate | 15 | $325 | $22 |
2017: 8 drugs
| Estrace | 38 | $11,836 | $311 |
| Estring | 14 | $6,180 | $441 |
| Premarin | 13 | $3,863 | $297 |
| Climara | 12 | $1,574 | $131 |
| Clobetasol Propionate | 14 | $1,519 | $109 |
| Estradiol | 31 | $629 | $20 |
| Alendronate | 23 | $471 | $20 |
| Medroxyprogesterone Acetate | 16 | $379 | $24 |
2016: 7 drugs
| Estrace | 48 | $13,662 | $285 |
| Premarin | 12 | $4,013 | $334 |
| Climara | 25 | $2,804 | $112 |
| Clobetasol Propionate | 13 | $1,901 | $146 |
| Estradiol | 27 | $756 | $28 |
| Medroxyprogesterone Acetate | 18 | $339 | $19 |
| Alendronate | 15 | $224 | $15 |
2015: 6 drugs
| Estrace | 39 | $9,564 | $245 |
| Premarin | 21 | $5,060 | $241 |
| Climara | 16 | $1,745 | $109 |
| Estradiol | 25 | $727 | $29 |
| Medroxyprogesterone Acetate | 30 | $587 | $20 |
| Alendronate | 19 | $283 | $15 |
2014: 6 drugs
| Estrace | 29 | $6,030 | $208 |
| Premarin | 20 | $4,397 | $220 |
| Climara | 11 | $1,250 | $114 |
| Estradiol | 30 | $521 | $17 |
| Medroxyprogesterone Acetate | 21 | $430 | $20 |
| Clobetasol Propionate | 13 | $208 | $16 |
2013: 5 drugs
| Estrace | 27 | $5,084 | $188 |
| Premarin | 24 | $4,412 | $184 |
| Estradiol | 41 | $839 | $20 |
| Medroxyprogesterone Acetate | 21 | $430 | $20 |
| Alendronate | 23 | $343 | $15 |
Professional record
- NPI
- 1841376779
- Licence
- CA G59309California G59309: Delinquent · expires 2024-10-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G593090
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2021-12-03
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.